• Explore /
  • Poster
  • / Efficacy and safety of PD-1/PD-L1 inhibitor plus platinum-based chemotherapy vs. platinum-based chemotherapy alone in patients with previously untreated advanced large-cell neuroendocrine cancer of the lung.

Efficacy and safety of PD-1/PD-L1 inhibitor plus platinum-based chemotherapy vs. platinum-based chemotherapy alone in patients with previously untreated advanced large-cell neuroendocrine cancer of the lung.

Abstract Poster

Authors

null

Fengchun Mu

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Fengchun Mu , Bingjie Fan , Haoqian Li , Taotao Dong , Yueyuan Yao , Butuo Li , Chao Jiang , Linlin Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9066)

DOI

10.1200/JCO.2023.41.16_suppl.9066

Abstract #

9066

Poster Bd #

54

Abstract Disclosures

Similar Posters

First Author: TAO Haitao

First Author: Panpan Zhang

First Author: Akshit Chitkara

First Author: Meiqi Shi